Tretinoin 0.05% Cream: Advanced Topical Retinoid for Photodamage and Acne
Tretinoin 0,05
| Product dosage: 20g | |||
|---|---|---|---|
| Package (num) | Per tube | Price | Buy |
| 4 | $12.25 | $49.00 (0%) | 🛒 Add to cart |
| 6 | $10.17
Best per tube | $73.50 $61.00 (17%) | 🛒 Add to cart |
Similar products
Tretinoin 0.05% cream is a prescription-strength topical retinoid formulation indicated for the treatment of acne vulgaris and mitigation of fine wrinkles, mottled hyperpigmentation, and tactile roughness associated with photodamage. As a biologically active metabolite of vitamin A, it modulates keratinocyte proliferation and differentiation, promotes collagen synthesis, and normalizes desquamation. This concentration represents a mid-potency option, balancing efficacy with tolerability for many patients. Clinical use requires professional supervision to optimize therapeutic outcomes while minimizing adverse effects.
Features
- Contains 0.05% tretinoin in a cosmetically elegant, non-comedogenic cream base
- Formulated for stability and consistent drug delivery
- pH-balanced to enhance skin compatibility
- Preservative system meets pharmaceutical standards
- Available in 20g, 45g, and 60g aluminum tubes with tamper-evident seals
Benefits
- Significantly reduces inflammatory and non-inflammatory acne lesions through follicular keratinization normalization
- Improves clinical signs of photodamage by stimulating neocollagenesis and epidermal remodeling
- Diminishes post-inflammatory hyperpigmentation through enhanced epidermal turnover
- Provides comedolytic activity to prevent microcomedone formation
- Offers dose-dependent efficacy with established safety profile
- Delivers therapeutic effects while maintaining skin barrier function with proper use
Common use
Tretinoin 0.05% cream is primarily prescribed for the management of mild to moderate acne vulgaris, particularly when comedones, papules, and pustules are present. It is equally employed as monotherapy or adjunctive treatment for photoaging, specifically addressing fine line reduction, improvement in skin texture, and evening of dyspigmentation. Off-label applications include treatment of certain keratinization disorders and adjunctive therapy in melasma management. The product is intended for facial application unless otherwise directed by a healthcare provider.
Dosage and direction
Apply a pea-sized amount to the entire affected area once daily, preferably in the evening. Cleanse skin with a mild, non-medicated cleanser and pat dry before application. Allow skin to completely dry (15-20 minutes) prior to application to reduce irritation potential. Dot cream evenly across forehead, cheeks, chin, and nose, then spread thinly to cover entire treatment area. Avoid immediate periorbital area, nasolabial folds, and mucous membranes. Initiate therapy with alternate-day application for the first 2-3 weeks to assess tolerance before progressing to nightly use. Duration of treatment continues as long as therapeutic benefit persists, typically for several months to years with appropriate monitoring.
Precautions
Sun protection is mandatory during treatment; use broad-spectrum sunscreen SPF 30+ daily and reapply every 2 hours during sun exposure. Avoid excessive sun exposure and artificial UV sources. Temporary worsening of acne may occur during initial weeks of treatment. Skin sensitivity, including increased susceptibility to wind or cold, may develop. Exercise caution with concomitant use of other potentially irritating products (astringents, abrasives, high-concentration alpha hydroxy acids). Not recommended for use immediately after hair removal procedures (waxing, laser). Discontinue use if pregnancy is suspected or confirmed. Contact with eyes, nostrils, mouth, and other mucous membranes should be avoided.
Contraindications
Hypersensitivity to tretinoin or any component of the formulation. Use during pregnancy (Category C) unless potential benefit justifies potential risk to fetus. Nursing mothers should exercise caution. Not recommended for patients with eczema, seborrheic dermatitis, or other chronic skin conditions that may compromise skin barrier function. Should not be applied to sunburned skin or open wounds. Contraindicated in patients with personal or family history of cutaneous lupus erythematosus.
Possible side effects
Most side effects are dose-dependent and often diminish with continued use:
- Erythema (60-80% of patients initially)
- Peeling and flaking (40-70%)
- Dryness and tightness (50-75%)
- Burning or stinging sensation (20-40%)
- Pruritus (15-30%)
- Photosensitivity (requires consistent sun protection)
- Rarely: blistering, crusting, severe irritation, hypopigmentation, or hyperpigmentation
Drug interaction
Concurrent use with other topical acne medications (benzoyl peroxide, salicylic acid, azelaic acid) may increase irritation potential—space applications by several hours. Avoid combination with topical antibiotics unless specifically directed. Exercise caution with topical corticosteroids due to potential for increased absorption. Photosensitizing medications (tetracyclines, fluoroquinolones, thiazides, phenothiazines) may enhance photosensitivity reaction. Retinoid oral medications (isotretinoin, acitretin) are absolutely contraindicated due to risk of hypervitaminosis A.
Missed dose
Apply as soon as remembered if still during the evening application window. If the next scheduled dose is approaching, skip the missed dose and resume regular schedule. Do not apply double the amount to compensate for missed application. Consistency in application supports optimal therapeutic outcomes, but occasional missed doses are not clinically significant in long-term treatment regimens.
Overdose
Topical overdose may manifest as severe erythema, peeling, burning, or stinging. Treatment involves immediate discontinuation until skin integrity restores, typically 3-7 days. Supportive care includes emollients and bland skincare. Systemic absorption through topical application is minimal, but excessive application to large body surface areas could potentially lead to vitamin A toxicity symptoms (headache, nausea, dizziness). In case of accidental ingestion, seek immediate medical attention—symptoms would resemble hypervitaminosis A.
Storage
Store at controlled room temperature (20-25°C or 68-77°F). Keep tube tightly closed when not in use. Protect from light and excessive heat. Do not freeze. Keep out of reach of children and pets. Discard any product that has changed color, consistency, or odor. Do not use after expiration date printed on packaging.
Disclaimer
This product is available by prescription only. The information provided does not replace professional medical advice, diagnosis, or treatment. Always consult with a qualified healthcare provider regarding any questions about a medical condition. Individual results may vary based on skin type, condition severity, and adherence to treatment protocol. Proper diagnosis should precede treatment initiation.
Reviews
Clinical studies demonstrate 60-75% reduction in acne lesions after 12 weeks of use with 0.05% tretinoin cream. In photoaging studies, 60% of patients showed significant improvement in fine wrinkles and skin texture after 24 weeks. Patient satisfaction surveys indicate 70% would continue long-term therapy based on efficacy results. Dermatologist assessments consistently rate this concentration as effective for maintenance therapy after initial higher-concentration treatment. Most common feedback notes the importance of gradual introduction and consistent moisturizer use to manage initial irritation phase.